Ozanimod is the first oral, once-daily sphingosine-1-phosphate receptor modulator approved for adults with relapsing forms of multiple sclerosis.
from WebMD Health https://www.webmd.com/lung/news/20200326/fda-clears-ozanimod-zeposia-for-ms-covid-19-delays-launch?src=RSS_PUBLIC
0 Comments:
Post a Comment